Lastly, the endpoint of all-cause mortality rather than cause-specific mortality could have influenced the results as for example GDF-15 is a biomarker seen in a broad range of (inflammatory) disease (processes) and not solely bound to cancer and/or HF. This evidence concerns the gene GDF15 and glycogen storage disease VI.